(Q42551434)

2 November 2017

title

Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis (English)

1 reference

2 November 2017

1 reference

1 reference

3

P C Hayes

1 reference

2 November 2017

1

E H Forrest

1 reference

2 November 2017

I A Bouchier

2

1 reference

2 November 2017

publication date

1 December 1996

1 reference

2 November 2017

published in

Journal of Hepatology

1 reference

2 November 2017

volume

25

1 reference

2 November 2017

issue

6

1 reference

2 November 2017

page(s)

909-915

1 reference

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Renal effects of drugs used in the treatment of portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Pharmacodynamic profile of carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Renal function impairment induced by change in posture in patients with cirrhosis and ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Computerised system for the continuous measurement of azygos venous blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

The Measurement of the Renal Venous Outflow in Man by the Local Thermodilution Method

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Beta-blocking agents with vasodilating action

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective first-pass extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Effect of isosorbide dinitrate, verapamil, and labetalol on portal pressure in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980296-0

7 January 2021

10.1016/S0168-8278(96)80296-0

Identifiers

DOI

1 reference

2 November 2017

1 reference